Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 17, 2023
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
[ Fri, Feb 17th 2023
] - WOPRAI
Thu, February 16, 2023
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
[ Thu, Feb 16th 2023
] - WOPRAI
Kyle Mikson Maintained (TXG) at Strong Buy with Increased Target to $58 on, Feb 16th, 2023
Kyle Mikson of Canaccord Genuity, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Increased Target from $55 to $58 on, Feb 16th, 2023.
Kyle has made no other calls on TXG in the last 4 months.
There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Kyle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023
This is the rating of the analyst that currently disagrees with Kyle
- Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $50 on, Wednesday, December 14th, 2022
